Marshall Posner, MD, talking from Palm Beach Cancer Symposium: Increased prevalence of HPV-related oropharyngeal cancers, more responsive to treatment with induction docetaxel, cisplatin, & 5-FU prior to standard chemoradiotherapy.

Marshall Posner, MD, talking from Palm Beach Cancer Symposium: Increased prevalence of HPV-related oropharyngeal cancers, more responsive to treatment with induction docetaxel, cisplatin, & 5-FU prior to standard chemoradiotherapy.

Marshall Posner, MD, talking from Palm Beach Cancer Symposium: Increased prevalence of HPV-related oropharyngeal cancers, more responsive to treatment with induction docetaxel, cisplatin, &amp; 5-FU prior to standard chemoradiotherapy.

Oropharyngeal Cancer: Better Outlook with HPV-Directed Therapies

Oncology Times reports essential clinical news for oncologists, hematologists and other cancer care professionals. Learn more about our award-winning journal!

Share Oropharyngeal Cancer: Better Outlook with HPV-Directed Therapies

Sign up to save your podcasts

Oropharyngeal Cancer: Better Outlook with HPV-Directed Therapies

Oropharyngeal Cancer: Better Outlook with HPV-Directed Therapies

More shows like Oncology Times - OncTimes Talk

Breast Cancer Trials